In September 2011, Dr. Harold Varmus appointed Dr. Edward Trimble as director of NCI's new Center for Global Health (CGH). Dr. Trimble, a graduate of Harvard College, earned degrees in medicine and public health from Johns Hopkins University. He trained in obstetrics and gynecology at Vanderbilt University Medical Center, then in gynecologic oncology at Memorial Sloan-Kettering Cancer Center. He has been recognized internationally as an expert in prevention, screening, treatment, and symptom management for women with cervical, ovarian, uterine, and other gynecologic cancers.
Since Dr. Trimble joined NCI in 1991, he has led NCI's national scientific program of treatment trials for gynecologic cancers and worked with colleagues worldwide to develop global research strategies for these diseases. He coordinated two of NCI's Clinical Announcements to focus attention on NCI-sponsored research findings that changed standard clinical practice. The first, in 1999, improved chemoradiation treatment for women with cervical cancer, and the second, in 2006, changed intraperitoneal chemotherapy for women with ovarian cancer.
Together with colleagues from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Heart, Lung, and Blood Institute (NHBLI), Dr. Trimble organized the trans-NIH International Clinical Research Subcommittee, which has worked to strengthen international collaboration in academic clinical trials. For his work at NCI, he has been awarded two Public Health Service Commendation Medals, six NIH Merit Awards, and the NCI Director's Gold Star Award.